Ebola vaccine immunity under the microscope: how long does protection last?
NCT ID NCT05313139
First seen Mar 28, 2026 · Last updated May 01, 2026 · Updated 5 times
Summary
This study looked at 133 health workers in the Democratic Republic of the Congo who had received the Ebola vaccine (rVSV-ZEBOV). The goal was to see how long their immune protection lasts by measuring both antibody levels and immune cells. Researchers want to understand if booster doses are needed to keep health workers safe from future outbreaks.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for IMMUNE RESPONSE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Institut National de Recherche Biomédicale (INRB)
Goma, Democratic Republic of the Congo
-
Institut National de Recherche Biomédicale (INRB)
Kinshasa, Democratic Republic of the Congo
Conditions
Explore the condition pages connected to this study.